Effects of roselle (Hibiscus sabdariffa Linn.), a Thai medicinal plant, on the mutagenicity of various known mutagens in Salmonella typhimurium and on formation of aberrant crypt foci induced by the colon carcinogens azoxymethane and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in F344 rats

被引:70
|
作者
Chewonarin, T
Kinouchi, T
Kataoka, K
Arimochi, H
Kuwahara, T
Vinitketkumnuen, U
Ohnishi, Y
机构
[1] Univ Tokushima, Sch Med, Dept Bacteriol, Tokushima 7708503, Japan
[2] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50002, Thailand
关键词
roselle; chemoprevention; colon cancer; azoxymethane; aberrant crypt foci; heterocyclic amines; medicinal plant; antimutagenicity; PhIP; Hibiscus sabdariffa;
D O I
10.1016/S0278-6915(99)00041-1
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The 80% ethanol extract of roselle (Hibiscus sabdariffa Linn.), a medicinal plant in Thailand, was examined for antimutagenic and chemopreventive activity in a colon carcinogenesis model. It reduced about 60-90% of the mutagenicity induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and other heterocyclic amines 2-amino-3-methylimidazo[4,5-f]quinoline (IQ),2-amino-3,4-dimethylimidazo[4,5-f]quinoline(MeIQ),2-amino-3,8-dimethylidazo[4,5-f]quinoxaline(MeIQx),3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1), 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P2),2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1),2-aminodipyrido[1,2-a:3',2'-d]imidazle (Glu-P-2), at a concentration of 12.5 mg/plate in the Salmonella mutation assay. The extract showed no mutagenicity and no antibacterial activity below this dose. Mutagenicity of methylazoxymethanol (MAM) acetate, which, like PhIP, is a colon carcinogen,was also efficiently inhibited by the roselle extract. To investigate chemoprevention by roselle in a colon carcinogenesis model, we examined the inhibitory effects of the roselle extract in F344 rats in which aberrant crypt focus (ACF) formation was induced by azoxymethane (AOM) and PhIP. In the initiation stage, the number of AOM-induced ACF in the colon was significantly decreased by roselle (17-25%) compared with that in rats treated with AOM alone. The amount of O-6-methylguanine in the colonic mucosa tended to be decreased in the roselle-treated rats. The number of PhIP-induced ACF was also significantly decreased by roselle treatment (22%) at a concentration of 1.0 g/kg body weight in the initiation stage. However, in the post-initiation stage of AOM-induced ACF formation, roselle increased the number of ACF, especially the number of foci which had more than three crypts/focus. These results indicate that roselle has antimutagenic activity against MAM acetate and heterocyclic amines and that it decreases the number of AOM- and PhIP-induced ACF in the initiation stage, although it rather increased the number of ACF in the post-initiation stage. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:591 / 601
页数:11
相关论文
共 43 条
  • [21] Tumor induction by azoxymethane (AOM) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in F344 rat gastric mucosa featuring intestinal metaplasia caused by X-irradiation
    Kashiwabara, S
    Kashimoto, N
    Uesaka, T
    Wakabayashi, K
    Kamiya, K
    Watanabe, H
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2005, 24 (02): : 305 - 312
  • [22] Induction of aberrant crypt foci in DNA mismatch repair-deficient mice by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP)
    Smith-Roe, Stephanie L.
    Lohr, Christiane V.
    Bildfell, Robert J.
    Fischer, Kay A.
    Hegan, Denise Campisi
    Glazer, Peter M.
    Buermeyer, Andrew B.
    CANCER LETTERS, 2006, 244 (01) : 79 - 85
  • [23] Effects of lactoferrin, soya germ and polyamine on 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine(PhIP)-induced breast carcinogenesis in rats
    Haba, R
    Watanabe, S
    Wada, M
    Udaka, S
    BIOFACTORS, 2004, 22 (1-4) : 127 - 131
  • [24] 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Induced Colon Injury by Disrupting the Intestinal Bacterial Composition and Lipid Metabolic Pathways in Rats
    Zhao, Xiuli
    Liu, Hengchao
    Zhou, Xiaofei
    Chen, Xiaoxu
    Hu, Nan
    Zhang, Yan
    Wang, Shuo
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2021, 69 (01) : 437 - 446
  • [25] Inhibitory effects of diallyl disulfide or aspirin on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary carcinogenesis in rats
    Suzui, N
    Sugie, S
    Rahman, KMW
    Ohnishi, M
    Yoshimi, N
    Wakabayashi, K
    Mori, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (08): : 705 - 711
  • [26] Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats
    Futakuchi, M
    Hirose, M
    Imaida, K
    Takahashi, S
    Ogawa, K
    Asamoto, M
    Miki, T
    Shirai, T
    CARCINOGENESIS, 2002, 23 (02) : 283 - 287
  • [27] Association between acetylator genotype and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) DNA adduct formation in colon and prostate of inbred Fischer 344 and Wistar Kyoto rats
    Purewal, M
    Fretland, AJ
    Schut, HAJ
    Hein, DW
    Wargovich, MJ
    CANCER LETTERS, 2000, 149 (1-2) : 53 - 60
  • [28] Induction of apoptosis in colonic epithelium treated with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its modulation by a P4501A2 inducer, β-naphthoflavone, in male F344 rats
    Hirose, Y
    Sugie, S
    Yoshimi, N
    Matsunaga, K
    Hara, A
    Mori, H
    CANCER LETTERS, 1998, 123 (02) : 167 - 172
  • [29] Strain differences of rats in the susceptibility to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine:: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility
    Ishiguro, Y
    Ochiai, M
    Sugimura, T
    Nagao, M
    Nakagama, H
    CARCINOGENESIS, 1999, 20 (06) : 1063 - 1068
  • [30] Chemopreventive properties of indole-3-carbinol (I3C):: Inhibition of DNA adduct formation of the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP), in female F344 rats
    He, YH
    Smale, MHE
    Schut, HAJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1997, : 42 - 51